Human Papillomaviruses in Transplant-Associated Skin Cancers

Dermatologic Surgery

Volumn 30, Issue 4 II, 2004, Pages 604-609

  Stockfleth, Eggert ^a   Nindl, Ingo ^a   Sterry, Wolfram ^a   Ulrich, Claas ^a   Schmook, Tobias ^a   Meyer, Thomas ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b Inst Immunol   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA PRIMASE; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; BASAL CELL CARCINOMA; CANCER CYTODIAGNOSIS; CANCER EPIDEMIOLOGY; COMPARATIVE STUDY; CONDYLOMA; CONTROLLED STUDY; DNA DETERMINATION; GRAFT REJECTION; HUMAN; HUMAN TISSUE; INFECTION RATE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; VIRUS DETECTION; VIRUS IDENTIFICATION; WART VIRUS;

EID: 1942443952     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2004.00144.x     Document Type: Article

References (32)

1. Stockfleth E, Ulrich C, Meyer T, Arndt R, Christophers E. Skin diseases following organ transplantation-risk factors and new therapeutic approaches. Transplant Proc 2001;33:1848-53.
2. Birkeland SA, Storm HH, Lamm LU, et al. Cancer risk after renal transplantation in the nordic countries, 1964-1986. Int J Cancer 1995;60:183-9.
3. Bouwes Bavinck JN, Hardie DR, Green A, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia: a follow-up study. Transplantation 1996;61:715-21.
4. Ziegler A, Leffell DJ, Kunala S, et al. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci USA 1993;90:4216-20.
5. Brash DE, Ziegler A, Kunala S, et al. Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J Invest Dermatol Symp Proc 1996;1:136-42.
6. Jensen P, Hansen S, Möller B, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999;40:177-86.
7. Glover MT, Deeks JJ, Raftery MJ, Cunningham J, Leigh IM. Immunusuppression and risk of non-melanoma skin cancer in renal transplant recipients. Lancet 1997;349:398.
8. Blessing K, McLaren KM, Benton EC, et al. Histopathology of skin lesions in renal allograft recipients: an assessment of viral features and dysplasia. Histopathology 1989;14:129-39.
9. Moy RL, Eliezre YD, Nuovo GJ, et al. Human papillomavirus type 16 DNA in periungual squamous cell carcinomas. JAMA 1989;261:2669-73.
10. McGregor JM, Proby CM. The role of papillomaviruses in human non-melanoma skin cancer. Cancer Surv 1996;26:219-36.
11. Pfister H, ter Schegget J. Role of HPV in cutaneous premalignant and malignant tumors. Clin Dermatol 1997;15:335-48.
12. Berkhout RJM, Bouwes-Bavinck JN, ter Schegget J. Persistence of human papillomavirus DNA in benign and (pre) malignant skin lesions from renal transplant recipients. J Clin Microbiol 2000;38:2087-96.
13. De Villiers EM, Lavergne D, McLaren KM, Benton EC. Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients. Int J Cancer 1997;73:356-61.
14. Harwood CA, Surentheran T, McGregor JM, et al. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000;61:289-97.
15. Meyer T, Arndt R, Christophers E, Nindl I, Stockfleth E. Importance of human papillomaviruses for the development of skin cancer. Cancer Detect Prev 2001;25:533-47.
16. Harwood CA, Proby CM. Human papillomaviruses and non-melanoma skin cancer. Curr Opin Infect Dis 2002;15:101-14.
17. Meyer T, Arndt R, Christophers E, Stockfleth E. Frequency and spectrum of HPV types detected in cutaneous squamous cell carcinomas depend on the HPV detection system: a comparison of four PCR assays. Dermatology 2000;201:204-11.
18. Meyer T, Arndt R, Nindl I, et al. Association of human papillomavirus infections with cutaneous tumors in immunosuppressed patients. Transplant Int 2003;16:146-53.
19. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor (NY): Cold Spring. Harbor Laboratory Press, 1989.
20. Manos MM, Ting Y, Wright DK, et al. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 1989;7:209-14.
21. Berkhout RJ, Tieben LM, Smits HL, et al. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol 1995;33:690-5.
22. Harwood CA, Spink PJ, Surentheran T, et al. Degenerate and nested PCR: a highly sensitive and specific method for detection of human papillomavirus infection in cutaneous warts. J Clin Microbiol 1999;37:3545-55.
23. Kwok S. Procedures to minimize PCR-product carry-over. In: Innis M, Gelfand D, Sninsky J, White T, eds. PCR Protocols: A Guide to Methods and Applications. San Diego: Academic Press, 1990. p. 356-67.
24. Meyer T, Arndt R, Stockfleth E, et al. Strategy for typing human papillomaviruses by RFLP analysis of PCR products and subsequent hybridization with a generic probe. Biotechniques 1995;19:632-9.
25. Nindl I, Jacobs M, Walboomers JMM, et al. Interlaboratory agreement of different human papillomavirus DNA detection and typing assays in cervical smears. Int J Cancer 1999;81:666-8.
26. Wieland U, Ritzkowsky A, Stoltidis M, et al. Papillomavirus DNA in basal cell carcinomas of immunocompetent patients: an accidental association? J Invest Dermatol 2000;115:124-8.
27. Orth G. Epidermodysplasia verruciformis. In: Salzman NP, Howley PM, eds. The Papovaviridae, the Papillomaviruses. New York: Plenum Press, 1987. p. 199-235.
28. Jackson S, Harwood C, Thomas M, Banks L, Storey A. Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev 2000;14:3065-73.
29. Frazer IH, Thomas R, Zhou J, et al. Potential strategies utilised by papillomavirus to evade host immunity. Immunol Rev 1999;168:131-42.
30. Stockfleth E, Meyer T, Benninghoff B, et al. A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses. Arch Dermatol 2002;138:1498-502.
31. Smith KJ, Germain M, Skelton H. Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy. Dermatol Surg 2001;27:561-4.
32. Stanley MA. Mechanism of action of imiquimod. Papillomavirus Rep 1999;10:23-9.